开发具有抗微生物活性的粉样酸:与它们的膜otropic活动的关系
Marta Balestra1, Lilia Leghmizi1, Thierry Drujon1
1Sorbonne Université, École normale supérieure, PSL University, CNRS, Laboratoire de Chimie Physique et Chimie du Vivant (CPCV), 75005 Paris, France.
Biochimica et biophysica acta. Biomembranes
|August 9, 2025
概括
新的抗微生物 (Amy-Cat) 结合了粉样和基域,可以有效杀死细菌. 这些药物表现出选择性膜破坏,为开发具有降低血溶性活性的新型抗菌疗法提供了有希望的途径.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 材料科学 材料科学 材料科学
背景情况:
- 抗菌素耐药性需要新的治疗策略.
- 基于的抗微生物药物为传统抗生素提供了一个有希望的替代品.
- 设计具有选择性膜破坏能力的质至关重要.
研究的目的:
- 开发和描述一类新的抗微生物,称为Amy-Cat.
- 为了研究艾米-猫的结构-活性关系,专注于粉样蛋白域.
- 评估Amy-Cat的选择性膜破坏活性和血液溶解潜力.
主要方法:
- 合成和调节Amy-Cat的不同粉样蛋白域和一个固定的非氨酸阴性基因的合成和调节.
- 确定针对格拉姆阴性和格拉姆阳性细菌的最小抑制度 (MIC).
- 在细菌和真核生物膜模型上使用色素染料泄漏试验评估膜性活性.
- 使用减弱总反射率-里埃变换红外光谱 (ATR-FTIR) 检测膜结合和构造变化.
主要成果:
- 艾米-猫对标准细菌菌株 (MICs 324μM) 具有广泛的杀菌活性.
- 的有效性保持在远低于引起血液溶解的度.
- 膜研究表明,调节粉样域的疏水性会影响选择性细菌膜破坏.
- 通过ATR-FTIR光谱,证实了粉样分子对膜相互作用和形状变化的影响.
结论:
- 艾米-猫代表了一种新型的两性抗菌剂类.
- 优化粉样蛋白域的疏水性允许选择性细菌膜向,最大限度地减少宿主细胞损伤.
- 艾米-猫体显示出开发下一代抗菌药物的巨大潜力.
更多相关视频
12:02An Efficient Method for the Synthesis of Peptoids with Mixed Lysine-type/Arginine-type Monomers and Evaluation of Their Anti-leishmanial Activity
Published on: November 2, 2016
12.2K
11:56Antimicrobial Peptides Produced by Selective Pressure Incorporation of Non-canonical Amino Acids
Published on: May 4, 2018
12.6K
相关概念视频
Antimicrobial Proteins
5.2K
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
5.2K
Amyloid Fibrils
9.9K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.9K
